Main content
First malaria vaccine approved for widespread use
Professor Sir Brian Greenwood and Thomas Breuer discuss the breakthrough.
The disease malaria causes widespread misery, especially across Africa. A vaccine developed in the UK by pharmaceutical company GSK has become the first to be approved for large-scale use. Justin Webb speaks to Professor Sir Brian Greenwood who has played a key role in the vaccine鈥檚 development and Thomas Breuer who is the Chief Global Health Officer at GSK.
Credit: Getty Images
Podcast
-
Best of Today
Listen to selected highlights from the Today programme.